Search

Gigi Georgiana Huang

Examiner (ID: 12753)

Most Active Art Unit
1613
Art Unit(s)
1618, 1627, 1629, 1609, 1612, 1613, 1617, 1621
Total Applications
781
Issued Applications
217
Pending Applications
66
Abandoned Applications
506

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6048816 [patent_doc_number] => 20110207809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHOD OF ACCELERATING CORNEAL WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 13/034889 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3441 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207809.pdf [firstpage_image] =>[orig_patent_app_number] => 13034889 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/034889
METHOD OF ACCELERATING CORNEAL WOUND HEALING Feb 24, 2011 Abandoned
Array ( [id] => 6186636 [patent_doc_number] => 20110124680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'NOVEL ANTHRANILAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/019530 [patent_app_country] => US [patent_app_date] => 2011-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12727 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124680.pdf [firstpage_image] =>[orig_patent_app_number] => 13019530 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/019530
NOVEL ANTHRANILAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR KINASE INHIBITORS Feb 1, 2011 Abandoned
Array ( [id] => 9551731 [patent_doc_number] => 08758776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Compositions and methods for treatment' [patent_app_type] => utility [patent_app_number] => 13/011775 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 33816 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011775 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/011775
Compositions and methods for treatment Jan 20, 2011 Issued
Array ( [id] => 9581715 [patent_doc_number] => 08771715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Compositions and methods for treatment' [patent_app_type] => utility [patent_app_number] => 13/011760 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 33817 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011760 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/011760
Compositions and methods for treatment Jan 20, 2011 Issued
Array ( [id] => 8313635 [patent_doc_number] => 20120190653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'THERAPEUTIC EYE DROP COMPRISING DOXYCYCLINE AND A STABILIZER' [patent_app_type] => utility [patent_app_number] => 13/009935 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7034 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13009935 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/009935
THERAPEUTIC EYE DROP COMPRISING DOXYCYCLINE AND A STABILIZER Jan 19, 2011 Abandoned
Array ( [id] => 6055706 [patent_doc_number] => 20110112066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'PREVENTIVE/REMEDY FOR RETINAL NERVE DISEASES CONTAINING ALKYL ETHER DERIVATIVES OR SALTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/008982 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30249 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112066.pdf [firstpage_image] =>[orig_patent_app_number] => 13008982 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/008982
Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof Jan 18, 2011 Issued
Array ( [id] => 8502070 [patent_doc_number] => 20120301478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular Permeability' [patent_app_type] => utility [patent_app_number] => 13/521395 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6198 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521395 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/521395
Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular Permeability Jan 12, 2011 Abandoned
Array ( [id] => 7733406 [patent_doc_number] => 20120015912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'USE OF 2,5-DIHYDROXYBENZENE FOR THE TREATMENT OF OCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 12/986674 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 25490 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015912.pdf [firstpage_image] =>[orig_patent_app_number] => 12986674 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/986674
Use of 2,5-dihydroxybenzene for the treatment of ocular diseases Jan 6, 2011 Issued
Array ( [id] => 8503193 [patent_doc_number] => 20120302601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF MACULAR DEGENERATION' [patent_app_type] => utility [patent_app_number] => 13/514769 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3837 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514769 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/514769
Compositions and methods for the treatment of macular degeneration Dec 8, 2010 Issued
Array ( [id] => 6118645 [patent_doc_number] => 20110076318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED MATTERS' [patent_app_type] => utility [patent_app_number] => 12/962427 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 23624 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076318.pdf [firstpage_image] =>[orig_patent_app_number] => 12962427 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/962427
RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED MATTERS Dec 6, 2010 Abandoned
Array ( [id] => 5995497 [patent_doc_number] => 20110114517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'HYDROGEN PEROXIDE SOLUTION AND KIT FOR DISINFECTING CONTACT LENSES' [patent_app_type] => utility [patent_app_number] => 12/948195 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8926 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20110114517.pdf [firstpage_image] =>[orig_patent_app_number] => 12948195 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/948195
HYDROGEN PEROXIDE SOLUTION AND KIT FOR DISINFECTING CONTACT LENSES Nov 16, 2010 Abandoned
Array ( [id] => 6127830 [patent_doc_number] => 20110086844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Oral Solid Solution Formulation of a Poorly Water-Soluble Active Substance' [patent_app_type] => utility [patent_app_number] => 12/945570 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4220 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086844.pdf [firstpage_image] =>[orig_patent_app_number] => 12945570 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/945570
Oral Solid Solution Formulation of a Poorly Water-Soluble Active Substance Nov 11, 2010 Abandoned
Array ( [id] => 6025785 [patent_doc_number] => 20110053845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'LOCALIZED VAGINAL DELIVERY WITHOUT DETRIMENTAL BLOOD LEVELS' [patent_app_type] => utility [patent_app_number] => 12/941840 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7297 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053845.pdf [firstpage_image] =>[orig_patent_app_number] => 12941840 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/941840
LOCALIZED VAGINAL DELIVERY WITHOUT DETRIMENTAL BLOOD LEVELS Nov 7, 2010 Abandoned
Array ( [id] => 6071182 [patent_doc_number] => 20110046033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function' [patent_app_type] => utility [patent_app_number] => 12/939262 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10135 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046033.pdf [firstpage_image] =>[orig_patent_app_number] => 12939262 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/939262
Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function Nov 3, 2010 Abandoned
Array ( [id] => 8465785 [patent_doc_number] => 20120270954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'METHODS FOR MAINTAINING EYE HEALTH AND AMELIORATING OPTHALMIC MALADIES IN CANINES' [patent_app_type] => utility [patent_app_number] => 13/503953 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5092 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503953 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/503953
METHODS FOR MAINTAINING EYE HEALTH AND AMELIORATING OPTHALMIC MALADIES IN CANINES Oct 21, 2010 Abandoned
Array ( [id] => 6196758 [patent_doc_number] => 20110028516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'STABILIZED AND PRESERVED KETOIFEN OPHTHALMIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/904675 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2481 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028516.pdf [firstpage_image] =>[orig_patent_app_number] => 12904675 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/904675
STABILIZED AND PRESERVED KETOIFEN OPHTHALMIC COMPOSITIONS Oct 13, 2010 Abandoned
Array ( [id] => 10567552 [patent_doc_number] => 09290710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Synergistic antimicrobial composition' [patent_app_type] => utility [patent_app_number] => 13/500220 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3147 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500220 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/500220
Synergistic antimicrobial composition Oct 7, 2010 Issued
Array ( [id] => 9375250 [patent_doc_number] => 08679511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts' [patent_app_type] => utility [patent_app_number] => 12/924495 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3551 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12924495 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/924495
In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts Sep 27, 2010 Issued
Array ( [id] => 5944994 [patent_doc_number] => 20110105614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'High Concentration Baclofen Preparations' [patent_app_type] => utility [patent_app_number] => 12/892627 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7077 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105614.pdf [firstpage_image] =>[orig_patent_app_number] => 12892627 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/892627
High concentration baclofen preparations Sep 27, 2010 Issued
Array ( [id] => 8382310 [patent_doc_number] => 20120225947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'RETINAL NEUROPROTECTION BY ION CHANNEL BLOCKERS REGULATED BY THE SUR SUBUNIT' [patent_app_type] => utility [patent_app_number] => 13/497938 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8109 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497938 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/497938
RETINAL NEUROPROTECTION BY ION CHANNEL BLOCKERS REGULATED BY THE SUR SUBUNIT Sep 22, 2010 Abandoned
Menu